2006
DOI: 10.1258/095646206778113087
|View full text |Cite
|
Sign up to set email alerts
|

Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women

Abstract: The high prevalence of abnormal cervical cytology in the context of immunosuppression has been recognized for many years. In response to repeated observations of cervical cancers in HIV-infected women, moderate and severe cervical dysplasia were designated as early symptomatic HIV infection (Category B) by the Centers for Disease Control and Prevention (CDC) in 1993, and invasive cervical cancer as an AIDS-defining condition (Category C). HIV-infected women, therefore, differ from the general population not on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
20
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 0 publications
0
20
0
Order By: Relevance
“…An even larger proportion (81%) of women reported adhering to the recommended annual Pap test. These findings are promising, but remain less than optimal given that WLH progress more rapidly to invasive cervical cancer, and have a lower rate of treatment success and survival compared to women without HIV [14, 15]. Additional efforts to promote recommended cervical cancer screening utilization are central to the survival of WLH as prevention and control (i.e., early intervention) are most critical for this population who bear excess burden of cervical disease.…”
Section: Discussionmentioning
confidence: 99%
“…An even larger proportion (81%) of women reported adhering to the recommended annual Pap test. These findings are promising, but remain less than optimal given that WLH progress more rapidly to invasive cervical cancer, and have a lower rate of treatment success and survival compared to women without HIV [14, 15]. Additional efforts to promote recommended cervical cancer screening utilization are central to the survival of WLH as prevention and control (i.e., early intervention) are most critical for this population who bear excess burden of cervical disease.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of cervical neoplasia among HIV-infected women ranges from 11% to 60%, and increases with the degree of immunosuppression 5–8 . Cervical cytologic abnormalities tend to progress more rapidly to invasive cervical cancer in HIV-infected than in non-infected women 9 .…”
Section: Introductionmentioning
confidence: 99%
“…Women living with HIV (WLWH) have an increased prevalence of Human Papillomavirus (HPV) infection [1,3-5], which is the main cause of ICC [1,3,6-8]. Furthermore, an increased risk of progression to cervical dysplasia and ICC is reported in WLWH compared to non-HIV-infected peers [1,3,7-11].…”
Section: Introductionmentioning
confidence: 99%